LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Ohio State University
Columbus, Estados UnidosPublicaciones en colaboración con investigadores/as de Ohio State University (2)
2022
-
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
Journal of Thoracic Oncology, Vol. 17, Núm. 2, pp. 289-308
2018
-
Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden
New England Journal of Medicine, Vol. 378, Núm. 22, pp. 2093-2104